Factor This Power Engineering
Live Events
DTECH® Events
POWERGEN™
INFOCAST Events
Calendar
Webinars
Podcasts
Factor This
This Week in Cleantech
Factor This Policycast
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
POWERGEN™
INFOCAST Events
Podcasts
Factor This
Factor This Policycast
This Week in Cleantech
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
SAB Biotherapeutics, Inc. - Common Stock
(NQ:
SABS
)
3.810
+0.190 (+5.25%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 25, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about SAB Biotherapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
12 Health Care Stocks Moving In Friday's After-Market Session
↗
September 19, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
September 19, 2025
Via
Benzinga
Top movers in Friday's session
↗
September 19, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Which stocks are gapping on Friday?
↗
September 19, 2025
The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via
Chartmill
Why Is SAB BIO Stock Trading Lower On Tuesday?
↗
January 28, 2025
SAB BIO's SAB-142 Phase 1 trial data supports its safety and pharmacodynamic activity, paving the way for a Phase 2b trial in T1D in 2025.
Via
Benzinga
SAB BIO Highlights Data in Multiple Presentations at EASD
September 19, 2025
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes
September 03, 2025
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
Which stocks are moving before the opening bell on Wednesday?
↗
September 03, 2025
Wondering what's happening in Wednesday's pre-market session? Find an overview in this article.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
September 03, 2025
Via
Benzinga
SAB BIO Reports Second Quarter Financial Results and Highlights Company Updates
August 07, 2025
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
July 23, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
July 21, 2025
Via
Benzinga
SAB BIO Announces Oversubscribed $175 Million Private Placement
July 21, 2025
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
May 29, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
May 21, 2025
Via
Benzinga
Gold Gains 1%; Boeing Shares Rise Following Q4 Results
↗
January 28, 2025
Via
Benzinga
SAB BIO Announces Q1 2025 Financial Results and Provides Company Updates
May 09, 2025
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
Nasdaq Surges More Than 300 Points; Lockheed Martin Shares Dip After Q4 Results
↗
January 28, 2025
Via
Benzinga
SAB BIO Reports Full Year 2024 Operating and Financial Results
March 31, 2025
SAB-142 Phase 1 trial positive topline data announced at KOL event
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
Dow Gains Over 50 Points; General Motors Posts Upbeat Earnings
↗
January 28, 2025
Via
Benzinga
Topics
Stocks
SAB BIO to Participate in Upcoming Investor Conferences
January 31, 2025
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
SAB BIO Announces Third Quarter 2024 Financial Results and Provides Company Update
November 06, 2024
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
SAB BIO Announces Positive Topline Phase 1 Clinical Results with Potentially Disease-Modifying T1D Therapy SAB-142
January 28, 2025
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
SAB BIO CEO to Participate in Fireside Chat at Guggenheim Securities Healthcare Innovation Conference
October 31, 2024
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
SAB BIO Announces R&D Webinar Event to Review Phase 1 Topline Results for SAB-142, a Disease-Modifying T1D Therapy
January 23, 2025
Investor webinar scheduled Tuesday, January 28, 2025, at 8:00 AM EST
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
October 18, 2024
Via
Benzinga
SAB BIO CEO to Participate in Fireside Chat at 2024 Cantor Global Healthcare Conference
September 13, 2024
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
SAB BIO Provides SAB-142 Clinical Trial Progress Update at the European Association for the Study of Diabetes Annual Meeting
September 09, 2024
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
SAB BIO to Present at the European Association for the Study of Diabetes 60th Annual Meeting
September 04, 2024
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
SABS Stock Earnings: SAB Biotherapeutics Beats EPS for Q2 2024
↗
August 09, 2024
SABS stock results show that SAB Biotherapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
